Tender

Aseptically Manipulated or Terminally Sterile Medicinal Products

  • Peninsula Purchasing & Supply Alliance

F02: Contract notice

Notice identifier: 2023/S 000-012809

Procurement identifier (OCID): ocds-h6vhtk-03c657

Published 4 May 2023, 2:09pm



The closing date and time has been changed to:

13 July 2023, 12:00pm

See the change notice.

Section one: Contracting authority

one.1) Name and addresses

Peninsula Purchasing & Supply Alliance

Royal Devon University Healthcare NHS Foundation Trust

Exeter

South west region

Contact

Fiona Malloch

Email

f.malloch@nhs.net

Telephone

+44 7867142061

Country

United Kingdom

Region code

UKK - South West (England)

National registration number

1234

Internet address(es)

Main address

https://www.royaldevon.nhs.uk/

Buyer's address

https://www.ppsa.nhs.uk/

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=67323&B=NHSSW

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

https://uk.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=67323&B=NHSSW

Tenders or requests to participate must be submitted to the above-mentioned address

one.4) Type of the contracting authority

Regional or local authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Aseptically Manipulated or Terminally Sterile Medicinal Products

Reference number

T22/0446

two.1.2) Main CPV code

  • 33600000 - Pharmaceutical products

two.1.3) Type of contract

Supplies

two.1.4) Short description

The supply of aseptically manipulated or terminally sterile products to NHS Trusts within the boundaries of the Peninsula Purchasing and Supply Alliance (PPSA). Products include national dose-banded cytotoxic and non-cytotoxic batch and patient specific medicines in ready-to-use infusion bags and pre-filled syringes.

This procurement is being managed by the Peninsula Purchasing and Supply Alliance (hereafter referred to as the PPSA) on behalf of the Royal Devon University Healthcare NHS Foundation Trust (hereafter referred to as the Organisation) acting for itself and for Gloucestershire Hospitals NHS Trust, Great Western Hospitals NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust, Salisbury NHS Foundation Trust, Somerset NHS Foundation Trust, Torbay & South Devon NHS Foundation Trust, University Hospitals Plymouth NHS Trust, North Bristol NHS Trust, University Hospitals Bristol & Weston NHS Foundation Trust and the Royal United Hospital Bath NHS Foundation Trust.

two.1.5) Estimated total value

Value excluding VAT: £80,500,000

two.1.6) Information about lots

This contract is divided into lots: Yes

Tenders may be submitted for all lots

two.2) Description

two.2.1) Title

Aseptically prepared products

Lot No

1

two.2.2) Additional CPV code(s)

  • 33690000 - Various medicinal products
  • 33692100 - Infusion solutions
  • 33692500 - Injectable solutions
  • 33692510 - Intravenous fluids
  • 33693100 - Toxins

two.2.3) Place of performance

NUTS codes
  • UKK - South West (England)
  • UK - United Kingdom
Main site or place of performance

Bristol, Devon, Cornwall, Gloucestershire, Somerset & Wiltshire

two.2.4) Description of the procurement

Supply of Cyclophosphamide, Doxorubicin & Pembrolizumab compounded ready-to-use batch and patient-specific products.

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.6) Estimated value

Value excluding VAT: £46,000,000

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

Lot 1 has the option to be extended for any period up to 36 months.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2.14) Additional information

The invitation to tender (ITT) documents and additional information is available from CTM e-procurement portal at https://uk.eu-supply.com

Tenders or requests to participate must be submitted electronically via the CTM e-procurement portal at https://uk.eu-supply.com

If not already registered on CTM eu-supply.com you will need to register as a supplier to express interest.

two.2) Description

two.2.1) Title

Aseptically prepared products

Lot No

2

two.2.2) Additional CPV code(s)

  • 33690000 - Various medicinal products
  • 33692100 - Infusion solutions
  • 33692500 - Injectable solutions
  • 33692510 - Intravenous fluids
  • 33693100 - Toxins

two.2.3) Place of performance

NUTS codes
  • UKK - South West (England)
Main site or place of performance

Bristol, Devon, Cornwall, Gloucestershire, Somerset & Wiltshire

two.2.4) Description of the procurement

Supply of Carboplatin, Epirubicin, Nivolumab & Paclitaxel.

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.6) Estimated value

Value excluding VAT: £25,000,000

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

The Contract for Lot 2 has the option to be extended for any period up to 36 months.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2) Description

two.2.1) Title

Aseptically Prepared Products

Lot No

3

two.2.2) Additional CPV code(s)

  • 33690000 - Various medicinal products
  • 33692100 - Infusion solutions
  • 33692500 - Injectable solutions
  • 33692510 - Intravenous fluids
  • 33693100 - Toxins

two.2.3) Place of performance

NUTS codes
  • UKK - South West (England)
Main site or place of performance

Bristol, Devon, Cornwall, Gloucestershire, Somerset & Wiltshire

two.2.4) Description of the procurement

Supply of Atezolizumab (Tecentriq®), Bortezomib Subcut, Docetaxel, Fluorouracil, Oxaliplatin & Vincristine.

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.6) Estimated value

Value excluding VAT: £9,000,000

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

Lot 3 has the option to be extended for any period up to 36 months.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No

two.2) Description

two.2.1) Title

Aseptically Prepared Products

Lot No

4

two.2.2) Additional CPV code(s)

  • 33690000 - Various medicinal products
  • 33692100 - Infusion solutions
  • 33692500 - Injectable solutions
  • 33692510 - Intravenous fluids
  • 33693100 - Toxins

two.2.3) Place of performance

NUTS codes
  • UKK - South West (England)
Main site or place of performance

Bristol, Devon, Cornwall, Gloucestershire, Somerset & Wiltshire

two.2.4) Description of the procurement

Supply of Bleomycin, Cabazitaxel, Calcium folinate, Cisplatin, Cytarabine, Daunorubicin, Ganciclovir, Suxamethonium & Vinblastine.

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.6) Estimated value

Value excluding VAT: £1,500,000

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

48

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

Lot 4 has the option to be extended for any period up to 36 months.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section three. Legal, economic, financial and technical information

three.1) Conditions for participation

three.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

three.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

four.2) Administrative information

four.2.2) Time limit for receipt of tenders or requests to participate

Originally published as:

Date

5 June 2023

Local time

2:00pm

Changed to:

Date

13 July 2023

Local time

12:00pm

See the change notice.

four.2.4) Languages in which tenders or requests to participate may be submitted

English

four.2.6) Minimum time frame during which the tenderer must maintain the tender

Duration in months: 8 (from the date stated for receipt of tender)

four.2.7) Conditions for opening of tenders

Date

6 June 2023

Local time

9:00am


Section six. Complementary information

six.1) Information about recurrence

This is a recurrent procurement: No

six.3) Additional information

The invitation to tender (ITT) documents and additional information is available from CTM e-procurement portal at: https://uk.eu-supply.com

Tenders or requests to participate must be submitted electronically via the above address.

This procurement (Lots 1, 2, 3 & 4 - RFT 73313) will be undertaken with Lot 5 framework (RFT 73320) and share the same T22/0446 Invitation to Tender documents (ITT).

The following Trusts may join any Contract(s) awarded from the Tender at any time during the Contract Period including Dorset County Hospital NHS Foundation Trust, Jersey General Hospital, Princess Elizabeth Hospital, Guernsey and University Hospitals Dorset NHS Foundation Trust.

six.4) Procedures for review

six.4.1) Review body

Peninsula Purchasing & Supply Alliance

Royal Devon & Exeter NHS Foundation Trust, Gladstone Road

Exeter

EX1 2ED

Country

United Kingdom

six.4.2) Body responsible for mediation procedures

Peninsula Purchasing & Supply Alliance

Royal Devon & Exeter NHS Foundation Trust, Gladstone Road

Exeter

EX1 2ED

Country

United Kingdom

six.4.4) Service from which information about the review procedure may be obtained

Peninsula Purchasing & Supply Alliance

Royal Devon & Exeter NHS Foundation Trust, Gladstone Road

Exeter

EX1 2ED

Country

United Kingdom